Home/Pipeline/SAVE Sensor System

SAVE Sensor System

Non-invasive assessment of hemodynamic congestion in heart failure

Clinical ValidationActive

Key Facts

Indication
Non-invasive assessment of hemodynamic congestion in heart failure
Phase
Clinical Validation
Status
Active
Company

About Acorai

Acorai is pioneering a non-invasive, multi-sensor platform for monitoring cardiac and pulmonary pressures, targeting the vast and underserved heart failure management market. Its SAVE Sensor System, which integrates seismic, acoustic, visual, and electric sensors, has been clinically tested in over 2,000 patients and seeks to address the critical need for accessible, frequent pressure monitoring outside invasive settings. As a private, pre-revenue company, Acorai's success hinges on securing regulatory approvals, demonstrating clinical utility to drive adoption, and navigating a competitive landscape of both established and emerging monitoring technologies. The company represents a compelling convergence of cardiovascular medicine and digital health innovation.

View full company profile